Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.

Kahn JA, Burk RD, Squires KE, Kapogiannis BG, Rudy B, Xu J, Gonin R, Liu N, Worrell C, Wilson CM.

J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):390-9. doi: 10.1097/QAI.0b013e3182676fe3.

2.

Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women.

Whittemore D, Ding L, Widdice LE, Brown DA, Bernstein DI, Franco EL, Kahn JA.

J Womens Health (Larchmt). 2016 Nov;25(11):1153-1158. Epub 2016 Oct 18.

3.

Risk perceptions after human papillomavirus vaccination in HIV-infected adolescents and young adult women.

Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K; Adolescent Trials Network for HIV/AIDS Interventions.

J Adolesc Health. 2012 May;50(5):464-70. doi: 10.1016/j.jadohealth.2011.09.005. Epub 2011 Nov 4.

4.
5.

Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women.

Shikary T, Bernstein DI, Jin Y, Zimet GD, Rosenthal SL, Kahn JA.

J Clin Virol. 2009 Oct;46(2):107-11. doi: 10.1016/j.jcv.2009.07.006. Epub 2009 Aug 8.

6.

Human papillomavirus vaccine and sexual behavior among adolescent and young women.

Liddon NC, Leichliter JS, Markowitz LE.

Am J Prev Med. 2012 Jan;42(1):44-52. doi: 10.1016/j.amepre.2011.09.024.

PMID:
22176845
7.

Risk of seropositivity to multiple oncogenic human papillomavirus types among human immunodeficiency virus-positive and -negative Ugandan women.

Namujju PB, Waterboer T, Banura C, Muwonge R, Mbidde EK, Byaruhanga R, Muwanga M, Surcel HM, Pawlita M, Lehtinen M.

J Gen Virol. 2011 Dec;92(Pt 12):2776-83. doi: 10.1099/vir.0.035923-0. Epub 2011 Aug 10.

PMID:
21832008
8.

Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.

Kahn JA, Rudy BJ, Xu J, Secord EA, Kapogiannis BG, Thornton S, Gillison ML.

Sex Transm Dis. 2015 May;42(5):246-52. doi: 10.1097/OLQ.0000000000000264.

9.

Cervical, anal and oral HPV in an adolescent inner-city health clinic providing free vaccinations.

Schlecht NF, Burk RD, Nucci-Sack A, Shankar V, Peake K, Lorde-Rollins E, Porter R, Linares LO, Rojas M, Strickler HD, Diaz A.

PLoS One. 2012;7(5):e37419. doi: 10.1371/journal.pone.0037419. Epub 2012 May 18.

10.

Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women.

Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S.

Clin Infect Dis. 2014 Jul 1;59(1):127-35. doi: 10.1093/cid/ciu238. Epub 2014 Apr 9.

11.

Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.

Remschmidt C, Fesenfeld M, Kaufmann AM, Deleré Y.

BMC Public Health. 2014 Dec 5;14:1248. doi: 10.1186/1471-2458-14-1248.

12.

Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years).

Guo F, Hirth JM, Berenson AB.

Hum Vaccin Immunother. 2015;11(10):2337-44. doi: 10.1080/21645515.2015.1066948.

13.

Distribution of human papillomavirus types, cervical cancer screening history, and risk factors for infection in Manitoba.

Demers AA, Shearer B, Severini A, Lotocki R, Kliewer EV, Stopera S, Wong T, Jayaraman G.

Chronic Dis Inj Can. 2012 Sep;32(4):177-85.

14.

Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women.

Kahn JA, Rosenthal SL, Jin Y, Huang B, Namakydoust A, Zimet GD.

Obstet Gynecol. 2008 May;111(5):1103-10. doi: 10.1097/AOG.0b013e31817051fa.

PMID:
18448742
15.

Prevalence of Anal Human Papillomavirus Vaccine Types in the Bangkok Men Who Have Sex With Men Cohort Study.

Cranston RD, Althouse AD, van Griensven F, Janocko L, Curlin ME, Chaikummao S, Chonwattana W, Siegel A, Holtz TH, McGowan I.

Sex Transm Dis. 2015 Dec;42(12):671-6. doi: 10.1097/OLQ.0000000000000372.

PMID:
26562695
16.

Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity.

Figueroa JP, Ward E, Luthi TE, Vermund SH, Brathwaite AR, Burk RD.

Sex Transm Dis. 1995 Mar-Apr;22(2):114-8.

PMID:
7624812
17.

Prevalence, incidence and persistence of genital HPV infections in a large cohort of sexually active young women in the Netherlands.

Mollers M, Boot Hein J, Vriend Henrike J, King Audrey J, van den Broek Ingrid VF, van Bergen Jan EA, Brink Antoinette AT, Wolffs Petra FG, Hoebe Christian JP, Meijer Chris JL, van der Sande Marianne AB, de Melker Hester E.

Vaccine. 2013 Jan 2;31(2):394-401. doi: 10.1016/j.vaccine.2012.10.087. Epub 2012 Nov 10.

PMID:
23146675
18.

Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth.

Liddon NC, Hood JE, Leichliter JS.

Vaccine. 2012 Mar 30;30(16):2676-82. doi: 10.1016/j.vaccine.2012.02.007. Epub 2012 Feb 15.

PMID:
22342548
19.
20.

Reduction of HPV infections through vaccination among at-risk urban adolescents.

Cummings T, Zimet GD, Brown D, Tu W, Yang Z, Fortenberry JD, Shew ML.

Vaccine. 2012 Aug 10;30(37):5496-9. doi: 10.1016/j.vaccine.2012.06.057. Epub 2012 Jun 28.

Supplemental Content

Support Center